drugset / Trial / NCT05666765

Comparison Between Isotretinoin, Silymarin and Both in the Treatment of Acne Vulgaris

NCT05666765

Phase 4 Unknown 75 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to compare the effects of isotretinoin and silymarin or both in treatment of acne and their effects on the level of IGF-1, SAA1 and malondialdehyde (MDA) in acne patients.

Timeline

Start
2023-01-01
Primary completion
2023-11-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Isotretinoin Other / unclassified 20 mg Oral
Subject Silymarin Traditional medicine (herbal / TCM) 140 mg

Indications